Neuromyelitis Optica (NMO)
3 clinical trials · Condition
◉ Watch Neuromyelitis Optica (NMO)
| Record | Firm | Date |
|---|---|---|
| Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD (NCT07132398) | Tianjin Medical University General Hospital | 2025-09-01 |
| Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD) (NCT02073279) | Hoffmann-La Roche | 2014-08-05 |
| Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) (NCT02028884) | Hoffmann-La Roche | 2014-02-20 |
Track Neuromyelitis Optica (NMO) automatically
Every clearance here is in the API, with alerts when new ones post.